628 Organometallics, Vol. 25, No. 3, 2006
Bertogg and Togni
(C), 67.2 (E), 70.4 (A), 76.1 (P), 92.9 (O), 113.2 (F,H), 127.9 (K,L),
128.6 (J), 131.4 (G), 136.2 (M), 154.2 (N). MS (HR MALDI): m/z
361.0765 (calcd for C20H19FeNO2); found 361.0760 [M+]. C20H19-
FeNO2 (361.22): calcd C 66.50, H 5.30, N 3.88, O 8.86, Fe 15.46;
found C 66.31, H 5.32, N 3.87. [R]22 ) +167 (c 1, CHCl3).
F), 104.0 (s, E), 128.2 (P), 128.5 (Q), 128.8 (d, JP ) 6.8 Hz, L),
129.4 (M), 133.7 (d, JP ) 17.4 Hz, O), 134.9 (d, JP ) 19.9 Hz, K),
136.9 (d, JP ) 18.6 Hz, J), 138.7 (d, JP ) 18.7 Hz, N). 31P NMR
(C6D6 121.5 MHz): δ 3.9. MS (HR MALDI): m/z 413.0996 (calcd
for C24H24FeNP); found 413.0950 [MH+]. C24H24FeNP (413.27):
calcd C 69.75, H 5.85, N 3.39 P 7.49, Fe 13.51; found C 69.46, H
6.10, N 3.32. The optical rotation and the melting point of 7 were
not determined due to its air sensitivity.
N,N′-Bis[(S)-2-{(1R)-1-(diphenylphosphino)ethyl}ferrocen-1-
yl]formamidine (1). A suspension of 6 (2.45 g, 4.48 mmol) in
iPrOH (30 mL) and H2O (20 mL) was degassed with Ar using an
ultrasonic bath and then treated with KOH (11.0 g). Stirring at 90
°C for 12 h led to a clear, red organic phase and a colorless aqueous
phase. Drying of the organic phase with MgSO4, filtration, and
evaporation of the solvents gave 7 as a orange to red solid. After
the addition of s-triazine (2.25 g, 27.8 mmol, 6.2 equiv) and dioxane
(6.0 mL), the resulting solution was stirred at 90 °C for 21 h and
the solvent was evaporated at reduced pressure using a distillation
apparatus. The product 1 was isolated as an orange foam after
column chromatography (SiO2, hexane/AcOEt/NEt3 ) 3:1:0.04).
Benzyl N-[(S)-2-{(1R)-1-(Diphenylphosphino)ethyl}ferrocenyl]-
carbamate (6). Diphenylphosphane (3.86 mL, 22.2 mmol, 4 equiv)
was added to a solution of 5 (2.00 g, 5.54 mmol, 1 equiv) in dry
acetic acid (9.0 mL) at rt. Stirring for 16 h at 65 °C, evaporation
of the solvent and of excess diphenylphosphane under reduced
pressure using a distillation apparatus, and washing with pentane
yielded a crude product that was recrystallized from iPrOH to give
6 as a red crystalline solid. Yield: 2.51 g (83%). Since no signal
1
Yield over the two steps from 6 to 1: 1.42 g (72%). H NMR
(CDCl3, 250.1 MHz): δ 1.54 (q, J ) 6.9 Hz, 6 H, 2 CH3), 3.44
(dq, Jq ) 6.5 Hz, Jd ) 6.0 Hz, 2 H, 2 CHmethyne), 3.93-3.99 (m, 4
H, 4 CHCp subst), 4.06-4.19 (m, 12 H, 2 CHCp subst and 2 Cpunsubst),
6.86 (s, 1 H, CHformamidinato), 6.99-7.08 (m, 4 H, CHarom.), 7.11-
7.19 (m, 4 H, CHarom.), 7.19-7.25 (m, 2 H, CHarom.), 7.36-7.43
(m, 6 H, CHarom.), 7.50-7.58 (m, 4 H, CHarom.). 13C{1H} NMR
(CDCl3, 62.9 MHz): δ 18.2 (bs, 2 CH3 methyl), 29.1 (bs, 2 CHmethyne),
63.1 (s, 2 CHCp subst), 63.2 (s, 2 CCp subst), 64.1 (s, 2 CHCp subst), 64.7
(s, 2 CCp subst), 69.5 (s, 2 Cpunsubst), 69.8 (s, 2 CHCp subst), 127.9 (2
CHarom.), 128.0 (2 CHarom.), 129.0 (2 CHarom.), 129.0 (2 CHarom.),
133.2 (2 CHarom.), 134.7 (2 CHarom.), 136.5 (2 CHarom.), 138.1 (2
CHarom.), 147.9 (bs, CHformamidinate). 31P NMR (CDCl3 101.3 MHz):
δ 6.1. IR (CHCl3) ν˜(cm-1) 1640 {ν(CdN) of amidine}. MS (HR
MALDI): m/z 837.1908 (calcd for C49H47Fe2N2P2); found 837.1916
[MH+]. C49H46Fe2N2P2‚1/2AcOEt (880.59): calcd C 69.56, H 5.72,
N 3.18, O 1.82, P 7.03, Fe 12.68; found C 69.58, H 5.70, N 3.21.
[R]22 ) -633 (c 1, CHCl3).
1
of a diastereomeric species could be detected in either the H or
31P NMR spectra, we assume a dr > 100:1. 1H NMR (CDCl3, 250.1
MHz): δ 1.55 (q, J ) 7.0 Hz, 3 H, A), 3.25 (dq, Jq ) 6.8 Hz, Jd
) 4.3 Hz, 1 H, B), 3.87-3.89 (m, 1H, E), 3.99 (dd, J1 ) 2.6 Hz,
J2 ) 2.6 Hz, 1 H, D), 4.12 (s, 5 H, T), 4.59 (bs, 1 H, C), 4.81 (bs,
1 H, NH), 4.98-5.11 (m, 2 H, H,J), 6.99-7.18 (m, 5 H, P,Q,R.),
7.31-7.45 (m, 8 H, L-N,X-Z), 7.49-7.58 (m, 2 H, L-N,X-Z).
13C{1H} NMR (CDCl3, 62.9 MHz): δ 18.2 (d, J ) 18.2 Hz, A),
30.0 (d, J ) 15.0 Hz, B), 59.9 (s, C), 63.2 (s, E), 63.4 (s, D), 66.7
(s, H,J), 69.5 (s, T), 83.1 (d, J ) 14.7 Hz, V), 93.9 (s, U), 128.0-
129.3 (m, L-N,Q-R,Y-Z), 133.0 (d, J ) 17.6 Hz, P), 134.0 (d,
J ) 19.6 Hz, X), 135.9 (d, J ) 16.0 Hz, O or W), 136.3 (d, J )
16.7 Hz, O or W), 153.3 (s, S). 31P NMR (CDCl3 101.3 MHz): δ
3.4. MS (HR MALDI): m/z 548.1442 (calcd for C32H31FeNO2P);
found 548.1436 [MH+]. C32H30FeNO2P (547.40): calcd C 70.21,
H 5.52, N 2.56, O 5.85, P 5.66, Fe 10.20; found C 69.99, H 5.63,
N 2.53, P 5.76. Mp ) 153.5 °C. [R]22 ) -375 (c 1, CHCl3).
N,N′-Bis{(S)-2-vinylferrocen-1-yl}formamidine (8). The Cbz-
protected aminoferrocene 5 (605 mg, 1.67 mmol, 1.0 equiv) was
suspended in iPrOH (12 mL) and KOH(aq) (12 mL, 5 M) and
quickly heated to 90 °C. After stirring for 4 h and cooling to rt, the
organic phase was separated from the aqueous layer, dried with
MgSO4, filtered, and concentrated to dryness under reduced
pressure. The orange solid was mixed with s-triazine (679 mg, 8.37
mmol, 5.0 equiv), dissolved in dioxane (3.0 mL), degassed, and
stirred at 100 °C for 28 h. After the addition of another portion of
s-triazine (679 mg, 8.37 mmol, 5.0 equiv) and further stirring for
26 h and cooling to rt, the reaction mixture was concentrated to
dryness under reduced pressure. Excess s-triazine was sublimed
by heating during 3 h at 80 °C, after which the crude product
obtained was subjected to column chromatography (SiO2, hexane/
EtOAc/NEt3 ) 3:1:0.04). Yield: 143 mg (37%) of a red amorphous
(S)-2-{(1R)-1-(Diphenylphosphino)ethyl}aminoferrocene (7;
the picture shows its conformation in solution). A suspension of 6
(2.39 g, 4.36 mmol) in iPrOH (30 mL) and H2O (30 mL) was
degassed with Ar using an ultrasonic bath and then treated with
KOH (16.5 g, results in a 9.8 M aqueous solution). Stirring at 90
°C for 17 h led to a clear, red organic phase and a colorless aqueous
phase. Drying of the organic phase with MgSO4, filtration, and
evaporation of the solvents gave 7 as a red solid. Yield: 1.66 g
(92%). For the yield of the direct conversion of 6 to 1 see the next
1
solid. H NMR (CDCl3, 250.1 MHz): δ 4.10-4.14 (m, 12 H, 10
CHCp subst and 2 CHCp unsubst), 3.34-3.38 (m, 2 H, 2 CHCp unsubst),
3.38-4.40 (m, 2 H, 2 CHCp unsubst), 5.20 (dd, J1 ) 11.0 Hz, J2 )
1.5 Hz, 1 H, vinyl H), 5.51 (dd, J1 ) 17.5 Hz, J2 ) 1.5 Hz, 1 H,
vinyl H), 6.67 (dd, J1 ) 17.5 Hz, J2 ) 11.0 Hz, 1 H, vinyl H),
8.00 (s, 1 H, CHformamidinato). 13C{1H} NMR (CDCl3, 125.8 MHz):
δ 61.1 (2 CH, Cpsubst), 63.2 (2 CH, Cpsubst), 64.8 (2 CH, Cpsubst),
70.6 (2 CH, Cpunsubst), 76.8 (2 C, Cp subst), 101.8 (2 C, Cpsubst), 113.0
(CHvinyl), 132.4 (CH2 vinyl), 151.5 (CHformamidinate). MS (HR MAL-
DI): m/z 465.0717 (calcd for C25H25Fe2N2); found 465.0703 [MH+].
C25H24Fe2N2 (464.17): calcd C 64.69, H 5.21, Fe 24.06, N 6.04;
found C 64.52, H 5.38, N 6.07. [R]22 ) -66.2 (c 1, CHCl3).
Benzyl N-[(S)-2-{(1R)-1-(3,5-dimethylpyrazol-1-yl)ethyl}-
ferrocenyl]carbamate (9). 3,5-Dimethylpyrazole (639 mg, 6.65
mmol, 5 equiv) was added to a solution of 5 (500 mg, 1.38 mmol,
1 equiv) in dry acetic acid (30 mL) at room temperature. Stirring
1
paragraph. H NMR (C6D6 500.2 MHz): δ 1.53 (bs, 2 H, NH2),
1.67 (dd, J1 ) 7.0 Hz, J2 ) 6.5 Hz, 3 H, H), 3.59 (dq, Jq ) 3.0 Hz,
Jd ) 6.0 Hz, 1 H, G), 3.79 (t, J ) 2.0 Hz, 1 H, D), 3.83 (t, J ) 2.5
Hz, 1 H, C), 3.89-3.90 (m, 1 H, B), 4.12 (m, 5 H, A), 7.05-7.11
(m, 3 H, P,Q), 7.23-7.29 (m, 3 H, L,M), 7.33-7.38 (m, 2 H, O),
7.67-7.72 (m, 2 H, K). 13C{1H} NMR (C6D6, 125.8 MHz): δ 18.6
(d, JP ) 17.9 Hz, H), 29.9 (d, JP ) 15.2 Hz, G), 59.9 (s, D), 61.9
(s, C), 63.4 (d, JP ) 4.7 Hz, B), 69.8 (s, A), 84.2 (d, JP ) 16.1 Hz,